CUSIP: G6S41R101
Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
18,060,944
-
Share change
-
-6,022,602
-
Total reported value
-
$1,565,761
-
Price per share
-
$0.09
-
Number of holders
-
27
-
Value change
-
-$3,633,900
-
Number of buys
-
14
-
Number of sells
-
16
Quarterly Holders Quick Answers
What is CUSIP G6S41R101?
CUSIP G6S41R101 identifies RVLPQ - OSMOTICA PHARMACEUTICALS PLC - SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2023
-
Previous quarter:
Q2 2023
Recent filing periods for CUSIP G6S41R101:
Institutional Holders of OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) as of Q3 2023
As of 30 Sep 2023,
OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,060,944 shares.
The largest 10 holders included
Athyrium Capital Management, LP, RENAISSANCE TECHNOLOGIES LLC, Blackstone Inc., GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Raymond James Financial Services Advisors, Inc., and TITLEIST ASSET MANAGEMENT, LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.